Innovative therapies and unique solutions

Solving the un(dis)solvable

We research and develop pioneering technology platforms that pave the way for innovative therapies to treat respiratory and ophthalmic conditions. We devise new patents, brands and products on the basis of scientific ideas.

Initial Public Offering

About us

Marinomed is a biopharmaceutical company that develops innovative products to treat respiratory and ophthalmic conditions on the basis of patent protected technology platforms. As well as working on research and development, Marinomed is already generating revenues from the Carragelose® platform and the sale of its products. The first product from the promising new Marinosolv® technology platform is about to be the subject of a pivotal clinical Phase III approval study.

Technology platforms

Where to meet us

BIO-Europe Spring

March 25-27, 2019 Vienna, Austria

ARVO 2019

April 28-May 2, 2019 Vancouver, BC

CPhI Worldwide

November 5-7, 2019 Frankfurt, Germany

BIO-Europe

November 11-13, 2019 Hamburg, Germany

Market

Product Launches